anmelden
FTSE All-Share
5.805,22
PKT
-9,88
PKT
-0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.04.26 | Diageo Buy | Deutsche Bank AG | |
| 15.04.26 | Diageo Neutral | Goldman Sachs Group Inc. | |
| 15.04.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 14.04.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 14.04.26 | Diageo Buy | Jefferies & Company Inc. | |
| 14.04.26 | Diageo Overweight | Barclays Capital | |
| 14.04.26 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 14.04.26 | BP Overweight | Barclays Capital | |
| 14.04.26 | BP Hold | Jefferies & Company Inc. | |
| 14.04.26 | BP Neutral | JP Morgan Chase & Co. | |
| 14.04.26 | GSK Hold | Deutsche Bank AG | |
| 14.04.26 | National Grid Outperform | Bernstein Research | |
| 14.04.26 | GSK Underweight | Barclays Capital | |
| 13.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 13.04.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.04.26 | National Grid Overweight | JP Morgan Chase & Co. | |
| 13.04.26 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 13.04.26 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.04.26 | Diageo Buy | Jefferies & Company Inc. | |
| 10.04.26 | GSK Neutral | UBS AG | |
| 10.04.26 | AstraZeneca Buy | UBS AG | |
| 10.04.26 | HSBC Buy | Goldman Sachs Group Inc. | |
| 10.04.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 10.04.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 09.04.26 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 09.04.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 09.04.26 | National Grid Sector Perform | RBC Capital Markets | |
| 09.04.26 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.26 | Unilever Kaufen | DZ BANK | |
| 08.04.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 08.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.04.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 07.04.26 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 07.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.04.26 | GSK Buy | Jefferies & Company Inc. | |
| 02.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.04.26 | BP Hold | Jefferies & Company Inc. | |
| 02.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. |
